MXL.NASDAQMaxlinear, INC

4/A: MaxLinear Director RSU Grant Correction

Sentiment:

Insider Transaction Amendment


MaxLinear Director Daniel A. Artusi filed an amended Form 4 to correct the number of Restricted Stock Units granted on May 20, 2025, now totaling 15,741.

Summary

  • Daniel A. Artusi, a Director of MaxLinear, Inc. (MXL), filed an amended Form 4 (Form 4/A) to correct previously reported information.
  • The amendment specifically corrects the number of Restricted Stock Units (RSUs) acquired on May 20, 2025.
  • The corrected amount of RSUs acquired is 15,741.
  • Each RSU represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
  • Following this transaction, Daniel A. Artusi beneficially owns 15,741 RSUs directly.
  • The RSUs will vest 100% on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, contingent on Mr. Artusi's continued service as a Director.

Sentiment

Score: 5

Explanation: The filing is an administrative correction to an insider transaction, which is neutral in sentiment. The underlying RSU grant itself is generally positive as it aligns director interests with shareholders.

Positives

  • The grant of Restricted Stock Units to Director Daniel A. Artusi aligns his financial interests with those of MaxLinear shareholders, promoting long-term value creation.

Future Outlook

The 15,741 Restricted Stock Units granted to Director Daniel A. Artusi are scheduled to vest 100% on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, provided he continues as a Director.

Industry Context

Equity compensation, such as Restricted Stock Units, is a common practice in the technology and semiconductor industry to attract, retain, and incentivize directors and executives, aligning their performance with shareholder interests.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) for director compensation is a standard practice across the technology sector, including companies like Broadcom (AVGO), Qualcomm (QCOM), and NVIDIA (NVDA), which frequently utilize equity grants to align executive and director incentives with long-term shareholder value.
  • The vesting schedule, tied to continued service, is typical for such grants, ensuring commitment from board members.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UtilizationThe RSU grant is subject to the company's 2010 Equity Incentive Plan, indicating the use of an established governance framework for equity compensation.05/20/2025Reinforces the existing corporate governance structure for executive and director compensation.

Related Party Transactions

  • The grant of 15,741 Restricted Stock Units to Daniel A. Artusi, a Director, constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the director's long-term interests with shareholder value creation, as the value of the RSUs is tied to the company's stock performance.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • The RSUs will vest on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, subject to Daniel A. Artusi's continued directorship.

Key Dates

DateDescription
05/20/2025Date of the RSU transaction.
05/22/2025Date the original Form 4 was filed.
10/10/2025Date the amended Form 4/A was signed.
05/01/2026Earliest potential vesting date for the RSUs.

Keywords

MaxLinear, MXL, Restricted Stock Units, RSU, Insider Transaction, Form 4/A, Director Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.